0001209191-18-038148.txt : 20180615
0001209191-18-038148.hdr.sgml : 20180615
20180615181108
ACCESSION NUMBER: 0001209191-18-038148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180613
FILED AS OF DATE: 20180615
DATE AS OF CHANGE: 20180615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROEDER DOUGLAS A
CENTRAL INDEX KEY: 0001270735
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37717
FILM NUMBER: 18903295
MAIL ADDRESS:
STREET 1: 160 BOVET RD, SUITE 408
STREET 2: C/O DELPHI VENTURES
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Senseonics Holdings, Inc.
CENTRAL INDEX KEY: 0001616543
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
IRS NUMBER: 471210911
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20451 SENECA MEADOWS PARKWAY
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
BUSINESS PHONE: (301) 515-7260
MAIL ADDRESS:
STREET 1: 20451 SENECA MEADOWS PARKWAY
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
FORMER COMPANY:
FORMER CONFORMED NAME: ASN Technologies, Inc.
DATE OF NAME CHANGE: 20140813
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-13
0
0001616543
Senseonics Holdings, Inc.
SENS
0001270735
ROEDER DOUGLAS A
160 BOVET RD. #408
SAN MATEO
CA
94402
1
0
0
0
Common Stock
2018-06-13
4
S
0
211832
3.9646
D
10510803
I
See Footnote
Common Stock
2018-06-13
4
S
0
2068
3.9646
D
102632
I
See Footnote
Common Stock
2018-06-14
4
S
0
153723
3.9645
D
10357080
I
See Footnote
Common Stock
2018-06-14
4
S
0
1501
3.9645
D
101131
I
See Footnote
Common Stock
2018-06-15
4
S
0
605355
4.049
D
9751725
I
See Footnote
Common Stock
2018-06-15
4
S
0
5910
4.049
D
95221
I
See Footnote
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 19, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.85 to $4.11, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.
The reported securities are directly owned by Delphi Ventures VIII, L.P. ("DV VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII"), the general partner of DV VIII, may be deemed to have sole dispositive and voting power over the securities directly owned by DV VIII. James J. Bochnowski, David L. Douglass, Deepika R. Pakianathan and Douglas A. Roeder are the managing members of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DV VIII. Such persons and entities disclaim the existence of a "group" and disclaim beneficial ownership of the securities held by DV VIII, except to the extent of any pecuniary interest therein.
The reported securities are directly owned by Delphi Bioinvestments VIII, L.P. ("DBI VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII"), the general partner of DBI VIII, may be deemed to have sole dispositive and voting power over the securities directly owned by DBI VIII. James J. Bochnowski, David L. Douglass, Deepika R. Pakianathan and Douglas A. Roeder are the managing members of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DBI VIII. Such persons and entities disclaim the existence of a "group" and disclaim beneficial ownership of the securities held by DBI VIII, except to the extent of any pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.87 to $4.08, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 5 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.98 to $4.16, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 6 to this Form 4.
/s/ Matthew T. Potter, Attorney-in-Fact for Douglas A. Roeder
2018-06-15